STAT Plus: Pharmalittle: Experts warn political squabbles should not delay coronavirus funding; Gilead to buy Forty Seven for $5 billion
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so-familiar routine of meetings, deadlines, phone calls, and what-not has, of course, returned. Despite the coronavirus, the world keeps spinning, in some fashion. So time to grab a cup of stimulation — hazelnut creme is the reliable choice today — and get things done. On that note, here are a few tidbits to help you along. Hope your day is manageable and productive.
Public health experts are warning Congress not to treat emergency coronavirus aid like business as usual, STAT says. Partisan bickering has often frustrated attempts to speedily approve emergency spending packages. Congress dawdled for seven months due to an acrimonious fight over funding for Zika in 2016, leaving health departments cash-strapped and forced to cut existing health programs. The delay left the federal government no choice but to plunder funds meant for cancer research, heart disease, and fighting HIV to pay for their response efforts.
Continue to STAT Plus to read the full story…
